Χώρα: Ηνωμένο Βασίλειο
Γλώσσα: Αγγλικά
Πηγή: MHRA (Medicines & Healthcare Products Regulatory Agency)
Donepezil hydrochloride
Rosemont Pharmaceuticals Ltd
N06DA02
Donepezil hydrochloride
1mg/1ml
Oral solution
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 04110000; GTIN: 5016119290893
14.01.16 THREE 301 1 of 2 Black DONEPEZIL HYDROCHLORIDE 1MG/1ML ORAL SOLUTION 1MG/1ML P0820 P0775 - - YES 150ML 210 x 300mm (folded 150 x 30mm) 1 Keyline PACKAGE LEAFLET: INFORMATION FOR THE USER DONEPEZIL HYDROCHLORIDE 1MG/1ML ORAL SOLUTION YOU AND YOUR CAREGIVER SHOULD READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE, BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU ■ Keep this leaflet. You may need to read it again. ■ If you have any further questions, ask your doctor or pharmacist. ■ This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. ■ If you get any of the side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet (see section 4). WHAT IS IN THIS LEAFLET: 1. What Donepezil Hydrochloride 1mg/1ml Oral Solution is and what it is used for 2. What you need to know before you take Donepezil Hydrochloride 1mg/1ml Oral Solution 3. How to take Donepezil Hydrochloride 1mg/1ml Oral Solution 4. Possible side effects 5. How to store Donepezil Hydrochloride 1mg/1ml Oral Solution 6. Contents of the pack and other information 1. WHAT DONEPEZIL HYDROCHLORIDE 1MG/1ML ORAL SOLUTION IS AND WHAT IT IS USED FOR Donepezil belongs to a group of medicines called acetylcholinesterase inhibitors. It is used to treat the symptoms of dementia in people diagnosed as having mild to moderately severe Alzheimer’s disease. The symptoms include increasing memory loss, confusion and behavioural changes. As a result, sufferers of Alzheimer’s disease find it more and more difficult to carry out their normal daily activities. Donepezil Hydrochloride 1mg/1ml Oral Solution is for use in adult patients only. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE DONEPEZIL HYDROCHLORIDE 1MG/1ML ORAL SOLUTION DO NOT TAKE DONEPEZIL HYDROCHLORIDE 1MG/1ML ORAL SOLUTION: ■ if you are allergic to (hypersensitive) to donepezil hydrochloride, or to piperidine derivatives, or any of Διαβάστε το πλήρες έγγραφο
OBJECT 1 DONEPEZIL HYDROCHLORIDE 1MG/1ML ORAL SOLUTION Summary of Product Characteristics Updated 07-Jun-2016 | Rosemont Pharmaceuticals Limited 1. Name of the medicinal product Donepezil Hydrochloride 1mg/1ml Oral Solution 2. Qualitative and quantitative composition Each ml of oral solution contains 1mg donepezil hydrochloride Excipients with known effect: D-Sorbitol 70% solution (E 420) 357mg/ml Methyl parahydroxybenzoate (E 218) 1mg/ml Sodium metabisulphite (E223) 0.2mg/ml For the full list of excipients, see section 6.1. 3. Pharmaceutical form Oral Solution A clear colourless liquid with a strawberry odour that is essentially free from visible foreign matter. 4. Clinical particulars 4.1 Therapeutic indications Donepezil is indicated for the symptomatic treatment of mild to moderately severe Alzheimer's dementia. 4.2 Posology and method of administration Posology Adults/Elderly: Treatment is initiated at 5 ml (5 mg)/day (once-a-day dosing) by filling the dosing spoon to the line of 5ml. Donepezil Hydrochloride 1mg/1ml Oral Solution should be taken orally, in the evening, just prior to retiring, and can be taken with or without food. The 5 mg/day dose should be maintained for at least one month in order to allow the earliest clinical responses to treatment to be assessed and to allow steady-state concentrations of donepezil hydrochloride to be achieved. Following a one-month clinical assessment of treatment at 5 mg/day, the dose of Donepezil Hydrochloride 1mg/ml Oral Solution can be increased to 10 ml (10 mg)/day (once-a-day dosing), by filling the dosing spoon to the line of 10ml. The maximum recommended daily dose is 10 mg. Doses greater than 10 mg/day have not been studied in clinical trials. Treatment should be initiated and supervised by a physician experienced in the diagnosis and treatment of Alzheimer's dementia. Diagnosis should be made according to accepted guidelines (e.g. DSM IV, ICD 10). Therapy with donepezil should only be started if a caregiver is available who will regularly monitor drug intake Διαβάστε το πλήρες έγγραφο